Construct/Measure | Methods of assessment | T0 Pre | T1 Post | T2 | T3 | T4 | T5 |
---|---|---|---|---|---|---|---|
Primary outcomes | Â | Â | Â | Â | Â | Â | Â |
Adherence | Objective: Monitor output | X | X | Â | Â | Â | Â |
 | Refill rate pharmacy | MR | MR |  | MR |  | MR |
 | Subjective: MAS, MOS-adhere | Q | Q | T | Q | T | Q |
Healthcare Consumption | Number of rehospitalisations, time to first HF-related hospitalization, visits to the GP and ER due to cardiac causes, DBC codes | MR | MR | MR | MR | MR | MR |
 | TiC-P, | Q | Q | T | Q | T | Q |
Secondary outcomes | Â | Â | Â | Â | Â | Â | Â |
Physical function, | 6-minute walk test | A | A | Â | A | Â | A |
disease progression | NYHA, LVEF | S | S | Â | S | Â | S |
Quality of life | KCCQ | Q | Q | Â | Q | Â | Q |
Predictors | Â | Â | Â | Â | Â | Â | Â |
Sociodemographic | Self-report, postal code area | Q | Â | Â | Â | Â | Â |
Self-care behavior | EHFScBS-9 | Q | Q | Â | Q | Â | Q |
Cognitive function | MMSE | A | A | Â | A | Â | A |
Depression | PHQ9, BDI10 | Q | Q | Â | Q | Â | Q |
Anxiety | GAD7, SAD4 | Q | Q | Â | Q | Â | Q |
Type D personality | DS14 | Q | Q | Â | Â | Â | Â |